In this edition of Where The Money Is, analysts David Williamson and Michael Douglass give their take on the week's biggest health care headlines.
This episode dissects Apple's (Nasdaq: AAPL) huge presentation yesterday, giving health care investors everything they need to know about how iPhone 6, Apple Watch, and the new IOS 8 HealthKit could take the sector by storm.
Other highlights include a massive deal between Google (Nasdaq: GOOG) Calico venture and big pharma Abbvie; a much needed win for a new Eli Lilly diabetes drug; a potential new weight loss drug from Novo Nordisk, and an important update regarding the alarming Ebola epidemic in Liberia.
The real winner is behind the Apple Watch (warning, it may shock you)
Apple recently revealed the product of its secret-development "dream team" -- Apple Watch. The secret is out, and some early viewers are claiming its everyday impact could trump the iPod, iPhone, and the iPad. In fact, ABI Research predicts 485 million of this type of device will be sold per year. But one small company makes Apple's gadget possible. And its stock price has nearly unlimited room to run for early in-the-know investors. To be one of them, and see where the real money is to be made, just click here!
No comments:
Post a Comment